FOR LABORATORY RESEARCH USE ONLY INDIA-WIDE ENQUIRY SUPPORT

COMPOUND RESEARCH GUIDE

MOTS-c in India: Research Guide, Evidence & Legal Status

MOTS-c is discussed widely online, often with more certainty than the evidence supports. This India-focused guide separates laboratory interest from demonstrated clinical outcomes.

Published by The Peptide Co.Updated

What researchers examine

MOTS-c is studied in mitochondrial signalling, metabolic homeostasis and cellular-stress models. The relevance of a result depends on material identity, model, comparator, endpoint and study design.

Laboratory and animal findings can identify mechanisms worth studying, but they do not by themselves establish safety or effectiveness in people.

How to read the evidence

Search for MOTS-c in PubMed and ClinicalTrials.gov, then identify whether each record is preclinical, observational or interventional. Check sample size, methods, endpoints, conflicts and publication status.

A mechanism, anecdote or registered trial is not regulatory approval. Evidence can also differ by formulation, manufacturer and jurisdiction.

India catalogue context

The linked MOTS-c product record shows the current laboratory presentation, INR catalogue price, research status and India-wide enquiry route.

It does not provide personal-use, dosage, administration, treatment or medical advice.

Legal status in India

MOTS-c is not an approved medicine in India as far as we are aware. It is listed as a laboratory research material only, not for human consumption. Check current CDSCO guidance or consult a legal professional for your own use case.

Our guide to the legal status of research peptides in India explains the difference between research materials and approved medicines.

Material identity before a literature comparison

Keep the exact MOTS-c in India material name, presentation and batch identifier alongside your research notes.

For each source, record the model, comparator, endpoint and relevant limitations. The papers below are selected starting points, not a systematic review or a test of our batches.

Before a laboratory procurement enquiry

Match the product record to the required presentation and request available batch documentation privately before payment. Compare the report identity, method and result with the actual material offered.

Use the catalogue for current prices and availability; the article update date is not a batch-test date.

Frequently asked questions.

What is MOTS-c?

MOTS-c is a research compound studied in mitochondrial signalling, metabolic homeostasis and cellular-stress models. It is listed by The Peptide Co. as a laboratory research material only.

Is MOTS-c legal in India?

MOTS-c is not an approved medicine in India as far as we are aware. It is supplied as a research-use-only laboratory material. This is general information, not legal advice; check current CDSCO guidance.

Where can I buy MOTS-c in India?

The Peptide Co. lists MOTS-c with INR prices on its product page and ships from Bengaluru across India. Standard delivery is ₹150 (3–5 days), express ₹350 (2–3 days) and cash on delivery ₹150 extra.

Selected studies and source context.

Curated starting points, not a systematic review, comparative ranking or batch-test record. Follow the source for the full methods and results.

Material, study model, measured topic and source limitations
SourceStudy modelMeasured topic and limitations
MOTS-c metabolic signalling study ↗Lee et al. · 2015 · PMID 25738459Cellular experiments and mouse models

Examines AMPK-linked signalling and metabolic homeostasis.

The discovery study is not a controlled human outcome study or a test of our catalogue batch.